Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Lion Biotechnologies
Work at Lion Biotechnologies?
Add yourself to this profile
3326
Lion Biotechnologies
We are a publicly traded #biotech company focused on the development of novel #cancer #immunotherapy products for #melanoma and other solid tumors.
Edit Profile
lbio.com
Health Care
>
Medical
Health Care
Technology
>
Biotechnology
B2c
Founded in
2013
Inactive
Raised
$100M
More info
Elsewhere
Companies in the same industry
eXIthera Pharmaceuticals
Bioverativ
Prosensa
Adnexus
Morphogen-IX
Comfort Line
BioFab
Addex Therapeutics
Beijing Allcure Medical Technology
Cartiva, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Post-IPO equity
$100,000,000
Frazier Healthcare Partners
,
OrbiMed Advisors
,
Broadfin Capital
, +1
Employees
Unknown size
Locations
HQ
United States
Headquarters
The Motley Fool
Why Lion Biotechnologies Inc. Stock Is Roaring Higher Today
$100,000,000
Post-IPO equity
PE Hub
Lion Biotechnologies racks up $100 mln, also hires new president/CEO
eXIthera Pharmaceuticals
Bioverativ
Prosensa
Comfort Line
BioFab
Addex Therapeutics